ABOUT THIS EVENT

Lyell Immunopharma, Inc. (Nasdaq: LYEL), a T cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors, rings the Nasdaq Closing Bell remotely from across the country.

In celebration of its IPO, Liz Homans, CEO, rings the Closing Bell alongside the Company’s team in a virtual bell ringing ceremony.